Literature DB >> 32008673

The Placental Basis of Fetal Growth Restriction.

Rebecca L Zur1, John C Kingdom2, W Tony Parks3, Sebastian R Hobson1.   

Abstract

Placental dysfunction is a major contributing factor to fetal growth restriction. Placenta-mediated fetal growth restriction occurs through chronic fetal hypoxia owing to poor placental perfusion through a variety of mechanisms. Maternal vascular malperfusion is the most common placental disease contributing to fetal growth restriction; however, the role of rare placental diseases should not be overlooked. Although the features of maternal vascular malperfusion are identifiable on placental pathology, antepartum diagnostic methods are evolving. Placental imaging and uterine artery Doppler, used in conjunction with angiogenic growth factors (specifically placenta growth factor and soluble fms-like tyrosine kinase-1), play an increasingly important role.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fetal growth restriction (FGR); Fetal vascular malperfusion (FVM); Intrauterine growth restriction (IUGR); Maternal vascular malperfusion (MVM); Placental dysfunction; Placental growth factor (PlGF); Placental insufficiency; Placental pathology

Mesh:

Year:  2019        PMID: 32008673     DOI: 10.1016/j.ogc.2019.10.008

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  26 in total

Review 1.  Immune dysfunction in developmental programming of type 2 diabetes mellitus.

Authors:  Thea N Golden; Rebecca A Simmons
Journal:  Nat Rev Endocrinol       Date:  2021-02-01       Impact factor: 43.330

2.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 3.  The Role of Kisspeptin in the Pathogenesis of Pregnancy Complications: A Narrative Review.

Authors:  Magdalena Szydełko-Gorzkowicz; Elżbieta Poniedziałek-Czajkowska; Radzisław Mierzyński; Maciej Sotowski; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

4.  Prenatal Prediction of Fetal Growth Restriction and Postnatal Outcomes by Ultrasound Assessment of Fetal Myocardial Performance Index and Blood Flow Spectrum.

Authors:  Yanchun Ma; Chunmin Li; Yan Wang; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-05       Impact factor: 2.650

5.  Interpretation of Wave Reflections in the Umbilical Arterial Segment of the Feto-Placental Circulation: Computational Modeling of the Feto-Placental Arterial Tree.

Authors:  Rojan Saghian; Lindsay Cahill; Anum Rahman; Joseph Steinman; Greg Stortz; John Kingdom; Christopher Macgowan; John Sled
Journal:  IEEE Trans Biomed Eng       Date:  2021-11-23       Impact factor: 4.538

6.  Induction of the PPARγ (Peroxisome Proliferator-Activated Receptor γ)-GCM1 (Glial Cell Missing 1) Syncytialization Axis Reduces sFLT1 (Soluble fms-Like Tyrosine Kinase 1) in the Preeclamptic Placenta.

Authors:  Brooke Armistead; Leena Kadam; Emily Siegwald; Fergus P McCarthy; John C Kingdom; Hamid-Reza Kohan-Ghadr; Sascha Drewlo
Journal:  Hypertension       Date:  2021-05-24       Impact factor: 9.897

7.  Strategies for intra-amniotic administration of fetal therapy in a rabbit model of intrauterine growth restriction.

Authors:  Mari Kinoshita; Fàtima Crispi; Carla Loreiro; Eduard Gratacós; Míriam Illa; Mònica Zamora
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-01

Review 8.  The promise of placental extracellular vesicles: models and challenges for diagnosing placental dysfunction in utero†.

Authors:  Lindsey N Block; Brittany D Bowman; Jenna Kropp Schmidt; Logan T Keding; Aleksandar K Stanic; Thaddeus G Golos
Journal:  Biol Reprod       Date:  2021-01-04       Impact factor: 4.161

9.  Nox2 impairs VEGF-A-induced angiogenesis in placenta via mitochondrial ROS-STAT3 pathway.

Authors:  Chengjun Hu; Zifang Wu; Zihao Huang; Xiangyu Hao; Shuqi Wang; Jinping Deng; Yulong Yin; Chengquan Tan
Journal:  Redox Biol       Date:  2021-06-18       Impact factor: 11.799

10.  Normative placental structure in pregnancy using quantitative Magnetic Resonance Imaging.

Authors:  Nickie Andescavage; Kushal Kapse; Yuan-Chiao Lu; Scott D Barnett; Marni Jacobs; Alexis C Gimovsky; Homa Ahmadzia; Jessica Quistorff; Catherine Lopez; Nicole Reinholdt Andersen; Dorothy Bulas; Catherine Limperopoulos
Journal:  Placenta       Date:  2021-07-31       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.